{"id":"W2754125339","doi":"10.17925/ee.2017.13.02.91","title":"Ranibizumab in Diabetic Macular Oedema – A Benefit–risk Analysis of Ranibizumab 0.5 mg PRN Versus Laser Treatment","year":2017,"lang":"en","type":"article","venue":"touchREVIEWS in Endocrinology","topic":"Retinal Diseases and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"Dalhousie University","funders":"NIHR Exeter Clinical Research Facility; National Institute for Health and Care Research; Pfizer; Eli Lilly and Company","keywords":"Ranibizumab; Medicine; Ophthalmology; Pro re nata; Visual acuity; Endophthalmitis; Laser coagulation; Diabetic macular edema; Diabetic retinopathy; Surgery; Bevacizumab; Diabetes mellitus","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01604746,0.0007666825,0.002380753,0.0009134231,0.0001770493,0.001158535,0.0005534397,0.0008547409,0.002822633],"category_scores_gemma":[0.01496533,0.0003798898,0.007593154,0.0005666947,0.0003940933,0.0008775046,0.0007398422,0.001471855,0.0002409161],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000684351,"about_ca_system_score_gemma":0.0006277816,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005120031,"about_ca_topic_score_gemma":0.0007073827,"domain_scores_codex":[0.9894112,0.007983883,0.0005856866,0.0006806795,0.001005979,0.0003325232],"domain_scores_gemma":[0.9857872,0.01077685,0.002233341,0.0004435751,0.0003126968,0.0004463051],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.792097,0.001306953,0.05309169,0.00338795,0.06318375,0.0002397372,0.0001713522,0.006913052,0.004763333,0.001089448,0.001336217,0.07241943],"study_design_scores_gemma":[0.1790267,0.2382401,0.2934678,0.001725356,0.2134268,0.0008729877,0.0004065995,0.04582477,0.004805672,0.008819475,0.01310317,0.0002804248],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9626061,0.02790807,0.003606672,0.0008994535,0.0002513143,0.0009947867,0.001324887,0.00004124172,0.002367406],"genre_scores_gemma":[0.9949155,0.001479196,0.00171459,0.0004064404,0.0001625793,0.0004104236,0.0004324902,0.00001136168,0.000467437],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01604746,"threshold_uncertainty_score":0.08486813,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04195603854146926,"score_gpt":0.3559446583775987,"score_spread":0.3139886198361295,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}